Curis (CRIS) Net Cash Flow (2010 - 2026)
Curis (CRIS) reported Net Cash Flow of $9.9 million for Q1 2026, up 3388.07% on a YoY basis from $285000.0 in Q1 2025, and up 349.15% quarter-over-quarter from -$4.0 million in Q4 2025.
Curis (CRIS) Net Cash Flow (2010 - 2026) Analysis & Trends
Curis has reported Net Cash Flow for 17 years, with the latest figure at $9.9 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow rose 3388.07% year-over-year to $9.9 million; the trailing twelve-month figure through Mar 2026 stood at -$5.3 million (up 45.42% YoY), and the FY2025 full-year result was -$14.9 million, down 123.46% from the prior year.
- Net Cash Flow for Q1 2026 stood at $9.9 million, up from -$4.0 million in the prior quarter.
- The five-year high for Net Cash Flow was $15.4 million in Q2 2022, with the low at -$21.5 million in Q1 2022.
- Historically, Net Cash Flow has averaged -$1.5 million across 5 years, with a median of -$857000.0 in 2024.
- Annual changes were most pronounced in 2025 — Net Cash Flow slumped 365.58% — and 2026, when it jumped 3388.07%.
- Curis' Net Cash Flow stood at -$10.2 million in 2022, then soared by 121.71% to $2.2 million in 2023, then plunged by 138.73% to -$857000.0 in 2024, then tumbled by 365.58% to -$4.0 million in 2025, then surged by 349.15% to $9.9 million in 2026.
- The last three Net Cash Flow figures came in at $9.9 million (Q1 2026), -$4.0 million (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 664,983.53 |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 9.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.94 Mn |
| Mar 31, 2026 | 9.94 Mn |
| Dec 31, 2025 | -3.99 Mn |
| Dec 31, 2025 | -3.99 Mn |
| Sep 30, 2025 | -1.09 Mn |
| Sep 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -10.14 Mn |
| Jun 30, 2025 | -10.14 Mn |
| Mar 31, 2025 | 285,000.00 |
| Mar 31, 2025 | 285,000.00 |
| Dec 31, 2024 | -857,000.00 |
| Dec 31, 2024 | -857,000.00 |
| Sep 30, 2024 | 10.86 Mn |
| Sep 30, 2024 | 10.86 Mn |
| Jun 30, 2024 | -19.96 Mn |
| Jun 30, 2024 | -19.96 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Dec 31, 2023 | 2.21 Mn |